News | Nuclear Imaging | March 03, 2022

The Society of Nuclear Medicine and Molecular Imaging posted this statement on its website regarding the current situation in Ukraine

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) deplores the recent invasion of Ukraine that has resulted in the death and injury of a large number of innocent men, women, and children—a horrifying contrast to our work to save lives and improve patient care.

March 3, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) deplores the recent invasion of Ukraine that has resulted in the death and injury of a large number of innocent men, women, and children—a horrifying contrast to our work to save lives and improve patient care.

SNMMI’s mission is to improve human health by advancing nuclear medicine, molecular imaging and radionuclide therapy. Given our global scope, SNMMI leadership must express its grave concern about the rapidly deteriorating situation in Ukraine. Many more lives will be lost in the coming days and weeks unless a peaceful resolution of this conflict is rapidly secured. In addition, Ukraine has 15 nuclear reactors providing half the power to the country and houses the Chernobyl nuclear facility, which requires intensive environmental management for safety purposes. Among the civilians threatened by this invasion are the workers who keep these nuclear power plants and the Chernobyl nuclear facility safe.

For these nuclear workers, for the healthcare professionals delivering nuclear medicine and other services, and most importantly, for the safety and welfare of the Ukrainian people, SNMMI urges an immediate cessation of the invasion and occupation of Ukraine and strongly supports a rapid and peaceful resolution of this conflict.

Our thoughts are with all those affected by this crisis in the Ukraine and around the world.

For more information: www.snmmi.org


Related Content

News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Radiopharmaceuticals and Tracers

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
arrow
News | Radiation Therapy

May 1, 2024 — Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK ...

Time May 01, 2024
arrow
News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 14, 2024 — PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of ...

Time February 14, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | PET Imaging

February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before ...

Time February 09, 2024
arrow
Subscribe Now